Adjuvant treatment may delay recurrence after surgical resection in patients with liver cancer

Posted on

Adjuvant treatment with atezolizumab and bevacizumab may delay recurrence after surgical resection in patients with liver cancer
Source: Read Full Article

Related posts:
  1. Sepsis test being trialled for newborn babies could miss 30% of cases
  2. Nearly 500K Aetna members affected by EyeMed security incident
  3. Good Survival, Outcomes With TARE for HCC
  4. Innate and adaptive immune responses to BNT162b2 vaccination in mice
  5. Study proves that antivenom reduces risk of skin necrosis in patients bitten by brown recluse spider
Related posts